Ehling R, Di Pauli F, Lackner P, Rainer C, Kraus V, Hegen H, Lutterotti A, Kuenz B, De Zordo T, Schocke M, Glatzl S, Loscher WN, Deisenhammer F, Reindl M, Berger T (2015) Impact of glatiramer acetate on paraclinical markers of neuroprotection in multiple sclerosis: a prospective observational clinical trial
Nevertheless, a comprehensive report of the subjective and physiological measures collected in this study was previously published 51
Additionally, an obstacle to drug treatment for obesity is that the drug is perceived as ineffective because the patient gains weight again when the drug is stopped
R., Labosky, P